BackEaston Pharmaceuticals Overview

Easton Pharmaceuticals Total Assets

Track Easton Pharmaceuticals's total assets ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$0.00

Peer trimmed avg / median

Loading

Easton Pharmaceuticals Total Assets History

Loading

Easton Pharmaceuticals vs. peers: Total Assets Comparison

Loading

Easton Pharmaceuticals Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Easton Pharmaceuticals (EAPH) FAQ

As of the most recent data (September 2023), EAPH shows a total assets of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, EAPH's total assets is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Easton Pharmaceuticals is outperforming or lagging.

Tracking EAPH's total assets over time shows whether Easton Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has Easton Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $0) with ownership activity and broader fundamentals.

Easton Pharmaceuticals's total assets is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.